| Tap a line for its trend | FY21Mar 2021 | FY20Mar 2020 | FY19Mar 2019 | FY18Mar 2018 | FY17 and earlierAlpha Plus |
|---|
| 90.76× | 73.05× | 59.94× | 68.50× | FY17 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.05× | 0.04× | 41.07× | 91.04× | ||
| 0.17× | 0.12× | 0.10× | — | ||
| 90.64× | 72.97× | 100.91× | — | ||
| 0.93× | 1.08× | 1.27× | 1.23× | ||
| −9.66× | −102.58× | 150.85× | −10.21× | ||
| 3.65× | −3.26× | 13.62× | −11.51× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY18 31/03/2018 | FY19 31/03/2019 | FY20 31/03/2020 | FY21 31/03/2021 | |
|---|---|---|---|---|---|
| Inventory Days (DIO) | 68.50 | 59.94 | 73.05 | 90.76 | |
| Receivable Days (DSO) | 91.04 | 41.07 | 0.04 | 0.05 | |
| Payable Days (DPO) | — | 0.10 | 0.12 | 0.17 | |
| Cash Conversion Cycle (days) | — | 100.91 | 72.97 | 90.64 | |
| Asset Turnover | 1.23 | 1.27 | 1.08 | 0.93 | |
| Cash Conversion (CFO/Net Income) | -10.21 | 150.85 | -102.58 | -9.66 | |
| CFO/EBITDA | -11.51 | 13.62 | -3.26 | 3.65 |